Leica Biosystems PD-L1 BOND antibody

Wednesday, 05 December, 2018 | Supplied by: Leica Microsystems Pty Ltd


Leica Biosystems’ PD-L1 BOND antibody is designed for use on the company’s fully automated BOND IHC and ISH staining platform.

The PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by Abcam on behalf of Merck KGaA, which owns all IP rights to this antibody. It joins the ALK (anaplastic lymphoma kinase) antibody as the latest addition to Novocastra’s growing lung menu of primary antibodies.

Leica Biosystems has optimised these two clones into a ready-to-use format for use on the BOND IHC and ISH staining platform. This allows labs to perform ALK and PD-L1 testing on the BOND system with rapid turnaround times, reliable staining and walk-away convenience.

Online: www.leica-microsystems.com
Phone: 1800 625 286
Related Products

Lumiprobe DusQ fluorescence quenchers

Lumiprobe offers a series of DusQ fluorescence quenchers with different spectral properties and...

Enzo Life Sciences SCREEN-WELL Epigenetics library

Enzo Life Sciences' SCREEN-WELL Epigenetics library contains 43 compounds with defined...

LSBio PathPlus Cancer Antibodies

The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd